Conclusion: The cardioprotective effects and low risk of hypoglycemia of GLP-1 RAs make them preferred agents in any multidisciplinary approach aiming to reduce CV disease burden and improve prognosis
DHE staining To assess ROS levels in DRG tissue, we used a dihydroethidine (DHE) fluorescent probe
This was the first trial to demonstrate cardiovascular risk reduction with a GLP-1 receptor agonist in a non-diabetic population
De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A: Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
In this context, cells reroute glutamine into the reductive carboxylation pathway: NADP + -dependent isocitrate dehydrogenase runs in reverse to convert -ketoglutarate (from glutamine) into citrate, which is cleaved to acetyl-CoA for fatty acid synthesis 98
: CLA